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ABSTRACT
Objectives: The aim of this study is to assess the validity of a
new condition-speciﬁc instrument measuring psychosocial
consequences of abnormal screening mammography (PCQ-
DK33).
Methods: The draft version of the PCQ-DK33 was com-
pleted on two occasions by 184 women who had received an
abnormal screening mammography and on one occasion by
240 women who had received a normal screening result. Item
Response Theories and Classical Test Theories were used to
analyze data. Construct validity, concurrent validity, known
group validity, objectivity and reliability were established by
item analysis examining the ﬁt between item responses and
Rasch models.
Results: Six dimensions covering anxiety, behavioral impact,
sense of dejection, impact on sleep, breast examination, and
sexuality were identiﬁed. One item belonging to the dejection
dimension had uniform differential item functioning. Two
items not ﬁtting the Rasch models were retained because of
high face validity. A sick leave item added useful information
when measuring side effects and socioeconomic conse-
quences of breast cancer screening. Five “poor items” were
identiﬁed and should be deleted from the ﬁnal instrument.
Conclusions: Preliminary evidence for a valid and reliable
condition-speciﬁc measure for women having an abnormal
screening mammography was established. The measure
includes 27 “good” items measuring different attributes of
the same overall latent structure—the psychosocial conse-
quences of abnormal screening mammography.
Keywords: adverse effects, false-positive reactions, mass
screening, questionnaire design.
Introduction
If a woman follows the European Union-
recommended biannual breast cancer screening
program for 20 years her lifetime risk for a false-
positive screening mammography will be 20% to
25%, possibly even higher [1]. In the UK, where
women aged 50–65 years are offered screening every
3 years, more than 50,000 women per year will receive
a false-positive screening mammography (hereafter
referred to as a false positive) [2]. False positives cause
signiﬁcant adverse consequences including costly
follow-up tests and an increased use of health-care
services [3–5]. In addition, numerous studies have
shown that women recalled for further investigations
after an abnormal screening mammography, later
conﬁrmed as a false positive, experience signiﬁcant
adverse psychosocial effects [6]. In these studies a
variety of questionnaires have been used to measure
the adverse effects. Except for one questionnaire most
of the instruments have been developed for other pur-
poses and have a more or less generic character [7].
A requirement for the validity of a questionnaire is
that it has high content relevance and high content
coverage [8]. A condition-speciﬁc measure insures
higher content coverage compared with measures
developed for generic conditions [9]. A review has
shown that some of the most frequently used generic
measures in the setting of breast cancer screening: the
General Health Questionnaire, the Hospital Anxiety
and Depression Scale and the State-Trait Anxiety
Inventory, have problems with language, content rel-
evance and content coverage [7]. McCaffery and
Barrat underline the importance of high content valid-
ity when using questionnaires to measure psychosocial
consequences of screening [10].
The Psychological Consequences Questionnaire
(PCQ) was developed in 1992 by Jill Cockburn to
measure the short-term psychosocial consequences of
the actual act of participation in breast cancer screen-
ing. It consists of 12 items covering negative aspects
and 10 items covering positive aspects of participation
[11]. The full PCQ (negative and positive items) has
been used in only one study of the process of partici-
pating in breast cancer screening [12]. The negative
items have predominantly been used in studies of the
adverse consequences of false positive and not of the
consequences of the actual participation [6]. Neverthe-
less, the content validity of the PCQ has never been
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tested in the setting of abnormal and false-positive
screening mammography [7].
When summing raw scores of items in a scale an
assumption of unidimensionality is made, that is, the
items describe different aspects of the same construct
and can be added [13,14]. When the response options
are categorical on an ordinal scale as in many ques-
tionnaires Item Response Theory (IRT) and Rasch
models can be used to assess the psychometric prop-
erties of the questionnaire. The Rasch models provide
formal representation of perfect measurement. Where
items are shown to ﬁt a Rasch model the measure can
be shown to posses criterion-related construct validity
[15], to be objective [16], sufﬁcient [17], and there-
fore also reliable [18]. Measurements are speciﬁc
objective if comparisons of measurements do not sys-
tematically depend on arbitrary choices made in con-
nection with measurement. The choice of items is, for
example, best regarded as an arbitrary choice of item
from a larger item bank. Speciﬁc objectivity thus
requires that comparison of two persons by one
version of a scale does not differ systematically from
comparisons using another similar set of valid items.
Similarly, comparison of two persons should not
depend on measurements on other persons [16]. For
these reasons the Rasch model is considered a valu-
able “gold standard” against which measures should
be compared. Reliability and different aspects of
validity can also be assessed using Classical Test
Theory (CTT) [8]. The relation between CTT and
IRT has been described by Holland and Hoskens [19]
and it may be an advantage to combine the two theo-
ries. Item analyses by Rasch models explore in-depth
the degree to which the requirements of construct
validity are met. Items are assumed to monotonically
relate to one dimension and they are assumed to be
locally independent. It is also assumed that there is no
differential item functioning (DIF), that is, where an
item functions differently in subpopulations such as in
an intervention group and a control group [15,20].
The sufﬁciency of the model support computation of
the raw scores. IRT analyses also explore how the
items included in each dimension are interrelated and
ordered on a latent trait (e.g., psychosocial conse-
quences of a false positive) [21].
The strength of analyses based on the Rasch Model
is that the model is build on preassumptions closer to
reality than analyses based on CTT [14,21]. The Rasch
models describe how item responses depend both on
person and item parameters. The person parameter is
assumed to be unidimensional but item parameters
may be multidimensional when item responses are
ordinal categories.
The purpose of this study was to validate a new
condition-speciﬁc instrument measuring psychosocial
consequences of abnormal screening mammography
(PCQ-DK33) using both IRT and CTT.
Materials and Methods
A qualitative study to assess the content validity of the
PCQ was conducted in a setting of abnormal screening
mammography. The qualitative study highlighted the
need to make radical changes to the questionnaire if it
was to be used in this setting. Therefore, the draft
version of the questionnaire statistically tested in the
present study can be regarded as a new condition-
speciﬁc instrument with 33 items (PCQ-DK33, see the
summary in Table 4). Data were collected at two
screening centers: the Copenhagen University Hospital
and Odense University Hospital.
Group 1–Time I
Over a period of 20 weeks from November 2002 all
women who were recalled because of an abnormal
screening mammography were consecutively included
in the study. Before any further examinations to estab-
lish if the abnormal screening result was true or false
the women were asked to complete two question-
naires: 1) the PCQ-DK33 with the items randomly
ordered, and 2) the Danish version of the Nottingham
Health Proﬁle (NHP).
The NHP is a questionnaire measuring health
status. It was originally developed in the UK [22] and
has been adapted into a large number of languages
including Danish [23,24]. The NHP consists of six
sections covering energy, pain, emotional reaction,
sleep, social isolation, and physical mobility. It was
selected as a comparator to assess concurrent validity
[8] for the present study because emotional reactions
and sleep problems are well covered by the measure. It
was hypothesized that the new instrument measuring
psychosocial consequences of abnormal screening
mammography would converge with the emotional
section of the NHP and diverges from the pain and
mobility sections.
Group 1–Time II
Two weeks after having completed the ﬁrst question-
naire package the women were sent the draft version of
the PCQ-DK33. At this point most of the women
would know whether their abnormal screening result
was false positive or whether they had breast cancer.
They were asked to complete the questionnaire and
return it in an enclosed stamped addressed envelope. It
was hypothesized that women received a diagnosis of
breast cancer experienced more severe psychosocial
consequences than women with a known false-positive
screening result (known group validity and responsive-
ness) [8,25]. It was also hypothesized that there would
be a decrease in the negative psychosocial conse-
quences from abnormal to known false-positive
screening result.
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Group 2
For each woman in Group 1 who had completed the
questionnaires at time I another two women were sent
the draft version of the PCQ-DK33 and asked to
return the completed questionnaire in an enclosed
stamped addressed envelope. These women had had a
normal screening mammography at the same time and
at the same clinic as the women in Group 1–Time I.
The recruitment procedure for women in Group 2 was:
if the screening mammography of a woman was abnor-
mal then the two women having a normal screening
mammography and being screened just before and
after this woman were included in Group 2. In contrast
to Group 1, where informed consent was obtained at
the recall clinics, it was not possible to obtained
informed consent before posting the test questionnaire
to the women in Group 2. For ethical and legal reasons
the test questionnaire was posted to the women by the
screening clinics anonymously and only the age of the
participants was disclosed for the researchers. There-
fore, it was not possible to send reminders to the
women in Group 2. It was hypothesized that women
with an abnormal screening result experienced more
severe psychosocial consequences than women with a
normal screening result (known group validity) [8,25].
In Group 1–Time I, 220 women were eligible. Of
these, 16 (7.3%) were not invited to participate
because of sick leave among the clinic staff. Of those
asked to participate 90.2% agreed to complete the
questionnaires. At Time II, 90.8% returned the PCQ-
DK33 after one reminder. In Group 2, 400 women
received the questionnaire by post and 60% were
returned. There were no statistically signiﬁcant differ-
ences in mean and range of age between the women in
the three groups. Figure 1 illustrates the data collection
including the numbers of women in each subgroup.
Three questionnaires were returned without being
completed. Among the remaining 588 questionnaires
0.3% to 1.9% randomly distributed missing values per
item were observed.
Item responses were analyzed by the conditional
distribution of items given total person scores to avoid
assumptions on the distribution of the latent trait
being measured. The pair-wise estimation procedure
implemented in software program RUMM2020 was
used to estimate the item parameters [26,27]. The
analysis of the ﬁt of item responses to the Rasch
model were based on analyses of residuals comparing
observed to expected item responses, both for separate
individuals and for different score groups. The overall
ﬁt of the model was assessed by the Wright-
Panchapakesan chi-square statistic summarizing stan-
dardized residuals over score groups and items [28].
Item ﬁt statistics summarizing standardized residuals
in different score groups were used to identify misﬁt-
ting items. Data from Group 1–Time I and Time II and
data from Group 2 were pooled for IRT analyses.
Nevertheless, the sick leave item was not included in
the Rasch analyses because the response options dif-
fered entirely from the response options in the remain-
ing 32 items. DIF relative to person covariates was
checked by analyses of variance examining the degree
to which individual residuals for speciﬁc items
depended on the covariates. Absence of evidence of
interaction between the covariates and the estimated
trait parameters were taken as evidence of DIF being
uniform. A small subgroup of 17 women undiagnosed
2 weeks after their abnormal screening mammography
was not included in the analyses of DIF.
Finally, the assumption of local independence was
checked by examination of the degree to which indi-
vidual residuals were correlated.
Reliability was assessed by Cronbach’s alpha deﬁn-
ing the lower bound for the test–retest correlation of
the raw scores [29,30] and by the so-called Person
Separation Index calculating the lower bound for the
test–retest correlation of the estimated values of the
latent trait being measured [31].
Data were analyzed with CTT by using the software
SPSS for Windows version 13.0 (SPSS Inc., Chicago,
IL, USA) and the software Mplus 2.14 for conﬁrma-
tory factor analysis [32]. For IRT analyses the software
RUMM2020 was used [26].
The study was approved by the local ethical com-
mittee.
Results
The initial item analysis of the complete set of 32 items
rejected the Rasch model. Strong evidence of local
dependence indicated that the PCQ-DK33 was not
unidimensional. The subsequent separate analyses
2 weeks later 
Group 1, time II
167 of 184 women with: 
• 89 false positive  
• 61 breast cancer 
• 17 undiagnosed 
Group 2
240 women with normal 
screening mammography 
Group 1, time I
184 women with abnormal 
screening mammography 
Figure 1 Data collection of the PCQ-DK33.
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conﬁrmed the multidimensionality expected from the
qualitative study on face and content validity of the
instrument.
Six items covering anxiety formed one dimension
and none of these items had DIF in either of the sub-
groups. In one of the six items, “felt terriﬁed” (No.
29), the thresholds of the response categories were not
in order (Fig. 2). Of eight items covering the impact on
behavior after abnormal screening mammography,
seven items ﬁtted the Rasch model and no DIF was
observed. Among the seven behavioral items the
thresholds of item “difﬁculty doing everyday things
around the house” (No. 28) were not in order (Fig. 3).
Six items describing the sense of dejection and sadness
after abnormal screening mammography ﬁtted the
Rasch model forming one dimension. Nevertheless, the
item “felt sad” (No. 14) had uniform DIF in two of
four subgroups as shown in Figure 4. After deleting
this item the ﬁve remaining items still ﬁtted the Rasch
model with all thresholds in order and no DIF.
From a content perspective the Rasch analyses con-
ﬁrmed three more dimensions each with two items.
These three dimensions described impact on breast
examination, sleep and sexuality. Nevertheless, in the
breast examination dimension both items had uniform
DIF. The item “examined my breasts” (No. 16) had
uniform DIF in the group received a diagnosis of breast
cancer compared with the remaining groups (Fig. 5)
and the item “examined my breasts in the mirror”
(No. 21) had uniform DIF in the group with normal
screening mammography compared with the remain-
ing groups (Fig. 6). In the sexuality dimension the
thresholds of the item “less interest in sex” (No. 31)
were not in order (Fig. 7).
Besides testing the six identiﬁed dimensions for DIF
in the sampled groups (Fig. 1), DIF was also tested for
age and screening center. These tests showed no DIF.
There was no local dependency among the items in
the identiﬁed dimensions.
The two sleeping items ﬁtting the Rasch model and
the item “taking sleeping tablets” are from a content
point of view equal to three of the ﬁve items included
in the sleep section of the NHP. Rasch analyses of the
sleep section of the NHP showed that four of the ﬁve
sleeping items ﬁtted the Rasch model except for the
sleeping tablet item.
The Wright-Panchapakesan chi-square ﬁt statistics,
the Person Separation Index and the Cronbach’s alpha
of the six dimensions ﬁtting the Rasch model in the
PCQ-DK33 are listed in Table 1. The ﬁt statistic of
the behavioral subscale is marginally signiﬁcant
(P = 0.039). Adjusting P-values to control the false
Person location (logits)
–2 –1 0
0.0
0.5
1.0 0
1
2
3
1 2 3 4 5 6 7 8
P
ro
ba
bi
lit
y
Figure 2 Category probability curve of item
29 “terriﬁed.” The logit scale from -2 to +8 on
the x-axis symbolizes the latent trait of anxiety,
with the severity of anxiety increasing toward
the right. The y-axis symbolizes the probability
of afﬁrming the response categories: 0 “not at
all,” 1 “a bit,” 2 “quite a bit,” and 3 “a lot.”
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Figure 3 Category probability curve of item 28
“difﬁculty doing things around the house.” The
logit scale from -3 to +4 on the x-axis symbol-
izes the latent trait of behavioral impact, with
the severity of negative impact increasing
toward the right.The y-axis symbolizes the prob-
ability of afﬁrming the response categories: 0
“not at all,” 1 “a bit,” 2 “quite a bit,” and 3 “a lot.”
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discovery rate and so avoid spurious signiﬁcant results
due to multiple testing suggested that the result should
be regarded as insigniﬁcant [33].
For each subgroup Table 2 shows the mean score,
the standard error of mean and the standard deviation
for all six dimensions ﬁtting the Rasch model.
Items numbered 1, 7, 9, 10, 25, 27, and 30 did not
ﬁt the Rasch model. The face validity of these items
was checked by re-auditing tape recordings from the
focus group interviews conducted during the adapta-
tion of the PCQ into Danish. The item “less attractive”
(No. 1) and the item “busy to take mind off things”
(No. 10) had signiﬁcant face validity for women who
had had surgery or had been on early recall after
abnormal screening mammography.
Cronbach’s alpha increased when deleting items 7,
25, 27, and 30 and dropped when deleting items 1, 9,
and 10. This indicated that items 7, 25, 27, and 30 were
“poor” items because alpha is expected to decrease
when valid items are deleted from a summated score.
A subsequent conﬁrmatory factor analysis was con-
ducted to estimate how the six dimensions and the
three single items (No’s 1, 10, and 14) were correlated.
The analysis revealed a positive correlation between all
six dimensions and the three single items. Only very
weak evidence was disclosed against a model assuming
that one latent trait lies behind the six dimensions and
the three single items of the PCQ-DK33 (P = 0.0463).
When testing for known group validity a statisti-
cally signiﬁcant difference was found between women
having an abnormal screening mammography and
those having a normal screening mammography. In all
six dimensions and in the three single items the P-value
of the Pearson chi-square was less than 0.0005. In the
single item about sick leave (No. 33) the P-value was
0.026.
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Figure 4 Item characteristics curves (ICC) of item 14 “felt sad” showing uniform differential item functioning (no statistical signiﬁcant difference between
the slopes of the three ICC) between the group of women received a diagnosis of breast cancer (i14bc), the group of women having normal screening
mammography (ni14no) and the remaining women – women having abnormal and a false-positive screening mammography (i14re).The logit scale from -7
to +5 on the x-axis symbolizes the latent trait of sense of dejection, with the severity of dejection increasing toward the right.The y-axis symbolizes the
values of responses options: 0 “not at all,” 1 “a bit,” 2 “quite a bit,” and 3 “a lot.” Label symbolizes the ICC for the three subgroups and Locn symbolizes
the item location.
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Figure 5 Item characteristics curves (ICC) of item 16 “examined my breasts” showing uniform differential item function (no statistical signiﬁcant
difference between the slopes of the two ICC) between the group of women received a diagnosis of breast cancer (i16bc) and the remaining women –
women having an abnormal, a false positive and a normal screening mammography (i16re).The logit scale from -6 to +4 on the x-axis symbolizes the latent
trait of breast examination, with the severity of breast examination increasing toward the right.The y-axis symbolizes the values of responses options: 0
“not at all,” 1 “a bit,” 2 “quite a bit,” and 3 “a lot.” Label symbolizes the ICC for the three subgroups and Locn symbolizes the item location.
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There was a statistically signiﬁcant difference
between women received a diagnosis of breast cancer
and those having a known false positive in ﬁve of the
six dimensions and in the three single items (No’s 1,
10, and 33) with the highest P-value as 0.016. The
sexuality subscale could not differ between women
received a diagnosis of breast cancer and those having
a known false-positive screening result. Additional
analyses on the sexuality subscales found no statisti-
cally signiﬁcant difference between women having an
abnormal screening mammography and those received
a diagnosis of breast cancer. They also showed no
difference between women having an abnormal screen-
ing mammography and those with a known false
positive.
As a test of concurrent validity the Pearson corre-
lation was established between the sections of the NHP
and all the 27 “good” items (24 items in the six iden-
tiﬁed dimensions and items 1, 10, and 14). The
Pearson correlation was also established for each of
Person location (logits)
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Figure 6 Item characteristics curves (ICC) of item 21 “examined my breasts in the mirror” showing uniform differential item functioning (no statistical
signiﬁcant difference between the slopes of the three ICC) between the group of women with a normal screening mammography (i21no) and the remaining
women—women having an abnormal, a false positive and true positive (breast cancer) screening mammography (i21re).The logit scale from -5 to +5 on
the x-axis symbolizes the latent trait of breast examination, with the severity of breast examination increasing toward the right.The y-axis symbolizes the
values of responses options: 0 “not at all,” 1 “a bit,” 2 “quite a bit,” and 3 “a lot.” Label symbolizes the ICC for the three subgroups and Locn symbolizes
the item location.
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Figure 7 Category probability curve of item
32 “not felt like having my breast caressed.The
logit scale from -5 to +4 on the x-axis symbol-
izes the latent trait of sexuality, with the sever-
ity of negative impact of sexuality increasing
toward the right. The y-axis symbolizes the
probability of afﬁrming the response categories:
0 “not at all,” 1 “a bit,” 2 “quite a bit,” and 3 “a
lot.”
Table 1 Wright-Panchapakesan (WP) ﬁt statistics, Person Separation Index and the Cronbach’s alpha of six dimensions in the
PCQ-DK33
Dimensions (number of items) WP c2 Degrees of freedom P-value Person separation index Cronbach’s alpha
Anxiety (6) 61.81 52 0.166 0.94 0.92
Behavioral (7) 67.71 49 0.039 0.88 0.86
Sense of dejection (5) 55.14 40 0.056 0.93 0.89
Sleep (2) 8.49 9 0.486 0.89 0.90
Breast examination (2 or 4*) 19.60 (28.34*) 8 (21*) 0.01 (0.131*) 0.68 (0.70*) 0.71
Sexuality (2) 7.06 10 0.720 0.81 0.83
*After item split according to the uniform differential item functioning found.
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the six Rasch-ﬁtting dimensions. The results conﬁrmed
the hypothesis made before the analysis (Table 3).
A summary of the results from the psychometric
analyses of the PCQ-DK33 are given in Table 4.
Discussion
Six Rasch-ﬁtting dimensions were identiﬁed encom-
passing 24 items. The dimensions cover: anxiety,
behavioral impact, sense of dejection, impact on sleep,
breast examination, and sexuality. The six dimensions
had sufﬁcient sensitivity to distinguish between groups
a priori hypothesized to be different. The correlations
between the six Rasch-ﬁtting dimensions and the six
sections of the NHP were also as could be expected
from a content point of view.
Two items not ﬁtting the Rasch models were
retained in the questionnaire because of high face
validity. These were concerned with “feeling less
attractive” and “kept busy to take mind off things.”
An item “felt sad” belonged to the dejection dimension
but had uniform DIF relative to diagnostic subgroups.
The six dimensions and these three single items con-
verged as expected with the emotional section of the
NHP and diverged as expected with the pain and the
physical mobility sections.
The sick leave item was not included in the original
Australian version of the PCQ. Nevertheless, it seems
to add useful information when measuring side effects
and socioeconomic consequences of breast cancer
screening.
Five “poor items” were identiﬁed. Four of these
misﬁtted the Rasch model and had low face validity.
Cronbach’s alpha also increased when they were
deleted. The ﬁfth “poor” item “being tired” showed an
unclear picture. Although, it did not ﬁt the Rasch
model and had low face validity, Cronbach’s alpha
dropped when it was deleted. Perhaps “being tired”
describes a too general condition. Therefore, it is sug-
gested that the ﬁve “poor” items should be deleted
from the ﬁnal instrument. It is worth mentioning that
one of the “poor” items “keeping things from those
who are close to you” is an item belonging to the
original Australian version of the PCQ [11].
Collecting questionnaire data under two different
conditions may result in biases. At time I, the women
completed the PCQ-DK33 at the recall clinic. Two
weeks later at time II the same women completed the
PCQ-DK33 at home. Some women had the additional
examinations at the recall clinic only one day after
receiving the letter about the abnormal screening
mammography. This short time interval made it nec-
Table 2 Mean scores, standard error of mean and standard deviation of all six dimensions
Anxiety Behavioral Dejection
Dimensions A B C D E A B C D E A B C D E
No* 178 52 97 16 232 173 50 97 16 231 179 52 96 15 234
Mean 6.39 7.38 3.04 4.38 0.97 3.53 4.96 1.72 3.63 0.47 5.38 6.10 2.25 3.73 1.03
SE mean 0.36 0.73 0.42 1.24 0.13 0.28 0.61 0.27 1.04 0.11 0.29 0.60 0.34 1.14 0.12
SD 4.77 5.30 4.18 4.95 2.00 3.68 5.30 2.63 4.16 1.63 3.94 4.33 3.29 4.42 1.84
Sleep Breast examination Sexuality
Dimensions A B C D E A B C D E A B C D E
No* 179 52 97 16 235 181 52 97 16 235 173 50 97 16 235
Mean 2.10 2.48 1.10 1.63 0.33 2.2† 1.7† 1.1† 1.1 0.7† 0.84 1.08 0.62 0.94 0.15
SE mean 0.15 0.34 0.18 0.46 0.06 0.1‡ 0.2‡ 0.1‡ 0.36 0.1‡ 0.11 0.26 0.15 0.46 0.04
SD 2.00 2.43 1.73 1.82 0.94 1.44 1.50 1.82 1.43 1.84 0.67
*Number of subjects included in the Rasch analyses
†Mean scores are estimated from the means of the person locations on the latent trait according to the uniform differential item functioning found in items 16 and 21.
‡The SE mean are estimated from the SE means of the person locations.
A, Group 1–Time I; B, Group 1–Time II, women received a diagnosis of breast cancer; C, Group 1–Time II, women with known false positive; D, Group 1–Time II, women
undiagnosed; E, Group 2.
Table 3 Concurrent validity (convergent and divergent validity) of 27 “good” items and the six identiﬁed dimensions of the
PCQ-DK33 and the sections of the NHP at time I–group 1
NHP sections 27 “good” items Anxiety Behavioral Dejection Sleep Breast examination Sexuality
Energy level 0.43 0.30 0.49 0.37 0.30 -0.05 0.30
Pain 0.15 0.15 0.14 0.13 0.14 -0.13 0.09
Emotional reaction 0.70 0.65 0.68 0.67 0.55 0.15 0.35
Sleep 0.48 0.38 0.40 0.39 0.69 0.12 0.20
Social isolation 0.26 0.27 0.29 0.24 0.25 0.01 0.11
Physical mobility 0.16 0.10 0.17 0.10 0.10 -0.17 0.13
The correlations are calculated as coefﬁcients from the Pearson correlation.
NHP, Nottingham Health Proﬁle.
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essary to complete the questionnaires at the recall
clinic instead of receiving it by post. Women complet-
ing a questionnaire at a clinic may “smarten up” their
answers to be polite. Therefore, the negative psycho-
social consequences of an abnormal screening mam-
mography would most likely be underestimated.
Three items showed DIF relative to diagnostic sub-
groups. If an item functions differently in subpopula-
tions other psychometric properties should determine
the “destiny” of the item. The qualitative study pre-
ceding the present study showed that the two items
forming the breast examination dimension cover an
important area in the context of abnormal and false-
positive screening mammography. The results from the
concurrent validity tests conﬁrmed that the breast
examination dimension measured something different
from the other ﬁve dimensions. Consequently, it would
be unwise to remove these items. Nevertheless, special
precautions should be taken when calculating scores of
this dimension. The content of the item “being sad” is
close to the content of the other ﬁve items in the
dejection dimension. Therefore, it seems reasonable to
delete this item if future studies continuously show
DIF.
Three items from three different dimensions had
problems with the order of thresholds. As seen in
Figures 2, 3 and 7 the disorder was caused by minor
problems. If future studies show the same pattern it
has to be decided whether the response categories “A
bit” and “Quite a bit” should be merged either by
rescoring the items or redesigning the layout.
Two items belonging to two different dimensions
showed a marginal misﬁt of probability to the Rasch
model (No.’s 19 and 26, Table 4). Nevertheless, the
overall ﬁt of the dimensions were satisfactory. Future
studies including the questionnaire will show whether
these ﬁndings are consistent.
It was surprising that the sexuality dimension only
distinguished between women having a normal and
women having an abnormal screening mammography.
This may indicate that the negative impact on sexuality
after having an abnormal screening result had not
declined or vanished 1 or 2 weeks after women were
“free from” cancer suspicion.
The convergence between the dimensions of
anxiety, behavior and dejection and the emotional
section of the NHP indicates some overlap between
these three dimensions. Only longitudinal studies will
reveal whether this overlap is caused by redundancy.
Nevertheless, removing any of the dimensions would
decrease content coverage. The lack of convergence
between the two dimensions “breast examination”
and “sexuality” and the emotional section of the NHP
contradicts redundancy among the six dimensions.
The establishment of a traditional test–retest reli-
ability coefﬁcient requires at least 2 to 4 weeks where
the condition for the respondents is stable [8,25]. The
condition for the women in group 1 changed dramati-
cally from time I to time II. At time I all women had
been told that their screening result was abnormal. At
time II nearly all women knew their diagnosis: breast
cancer or false positive. A satisfactory reliability of the
measure was assessed with Cronbach’s alpha and
Person Separation Index (Table 1).
As shown in the Rasch analyses; four of ﬁve NHP
sleep-items ﬁtted the model. Two of the four items are
content-wise equivalent to the two Rasch-ﬁtting items
of the PCQ-DK33. Therefore, adapting the two non-
equivalent sleep items from the NHP would probably
add nuances to the sleep dimension of the new
instrument.
As in many other questionnaires, the response
options of the PCQ-DK33 are ordered categories.
Several models for ordinal categorical responses have
been suggested. The model used in the present study is
the partial credit model (PCM) in which the item
parameters are sometimes described as threshold
parameters [34]. The thresholds in the PCM may differ
between items. In contrast, the rating scale model
assumes that thresholds are homogenous across items
apart from an additive factor describing the item dif-
ﬁculty [35]. Rating scale models were considered
during the analysis but abandoned because of lack of
ﬁt between the model and the observed item responses.
The present study has shown the advantages of
combining analyses based on IRT and CTT when
assessing the psychometric properties of a question-
naire including dimensionality and “good” and
“poor” single items. After establishing unidimension-
ality with the Rasch model CTT analyses were subse-
quently conducted. This order of analyses had several
advantages: First, more than half of the Rasch-
misﬁtting items were conﬁrmed also to be “poor” by
the analyses of Cronbach’s alpha. Second, the internal
consistency expressed as a Cronbach’s alpha coefﬁ-
cient was calculated only on items included in the
Rasch-ﬁtting dimensions. Third, the results of testing
known group validity and concurrent validity were
only established on “good” items.
Conclusion and Perspectives
In conclusion, the reliability and the construct validity
of a condition-speciﬁc measure with high content
validity for women having an abnormal screening
mammography have been preliminary demonstrated.
This new questionnaire covers the impact of experi-
encing an abnormal screening mammography on:
anxiety, behavior, dejection, sexuality, sleep, and breast
examination. In addition, the measure includes three
single items covering: sick leave, feeling less attractive,
and kept busy to take mind off things.
The new instrument is currently in use in a major
Danish survey and has been translated into Dutch,
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English, and Norwegian. Future analyses on data from
surveys will be hoped to give an answer to the ques-
tions left from the present study:
• Should all the three single items be retained in the
ﬁnal version of the measure?
• Do the four items covering sleep form one dimen-
sion?
• Will the item “felt sad” still have uniform DIF?
• Will some items still have thresholds that are not
in order?
We are in great debt to the late professor Jill Cockburn for
her inspiration and strong supported of developing a
condition-speciﬁc measure of psychosocial consequences of
abnormal and false-positive screening mammography. We
want to thank the staff at the breast cancer screening clinic
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to this study.
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